New drug for sickle cell disease

Sickle cell disease is an inherited blood disorder in which the red blood cells are abnormally shaped. This restricts the flow in blood vessels and limits oxygen delivery to the body’s tissues, causing to severe pain and organ damage.

The U.S. Food and Drug Administration has approved Endari (L- glutamine oral powder) for patients five years and above  with sickle cell disease to reduce severe complications associated with the blood disorder.

The average life expectancy for sickle cell patients is 40 to 60 years. Common side effects of Endari are constipation, nausea, headache, abdominal pain, cough and pain in the extremities
          haleplushearty.blogspot.com